David I. Marks

20.8k total citations · 5 hit papers
162 papers, 9.8k citations indexed

About

David I. Marks is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, David I. Marks has authored 162 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Hematology, 82 papers in Public Health, Environmental and Occupational Health and 42 papers in Oncology. Recurrent topics in David I. Marks's work include Acute Lymphoblastic Leukemia research (81 papers), Hematopoietic Stem Cell Transplantation (63 papers) and Chronic Myeloid Leukemia Treatments (45 papers). David I. Marks is often cited by papers focused on Acute Lymphoblastic Leukemia research (81 papers), Hematopoietic Stem Cell Transplantation (63 papers) and Chronic Myeloid Leukemia Treatments (45 papers). David I. Marks collaborates with scholars based in United Kingdom, United States and Germany. David I. Marks's co-authors include Lucy Yardley, Hillard M. Lazarus, Martin S. Tallman, Mark R. Litzow, Adele K. Fielding, Richard E. Champlin, Jacob M. Rowe, Andrew McMillan, Mary M. Horowitz and Anthony H. Goldstone and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Oncology.

In The Last Decade

David I. Marks

153 papers receiving 9.6k citations

Hit Papers

Outcomes after Transplantation of Cord Blood or Bone Marr... 2004 2026 2011 2018 2004 2004 2006 2007 2024 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia
    2004 783 citations Mary J. Laughlin, Mary Eapen et al. profile →
  2. Research Methods for Clinical and Health Psychology
    2004 659 citations David I. Marks, Lucy Yardley profile →
  3. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
    2006 591 citations Adele K. Fielding, Susan Richards et al. Blood profile →
  4. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
    2007 537 citations Anthony H. Goldstone, Susan Richards et al. Blood profile →
  5. Management of ALL in adults: 2024 ELN recommendations from a European expert panel
    2024 45 citations Nicola Gökbuget, Nicolas Boissel et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David I. Marks United Kingdom 47 6.4k 3.9k 2.6k 1.6k 1.5k 162 9.8k
Henrik Hasle Denmark 53 4.3k 0.7× 3.0k 0.8× 1.4k 0.5× 1.2k 0.8× 1.2k 0.8× 311 9.1k
Scott D. Rowley United States 44 5.2k 0.8× 807 0.2× 2.6k 1.0× 1.7k 1.1× 1.6k 1.1× 168 8.0k
George R. Buchanan United States 57 8.0k 1.2× 1.3k 0.3× 1.0k 0.4× 908 0.6× 5.0k 3.4× 313 12.6k
Naveen Pemmaraju United States 46 5.1k 0.8× 1.4k 0.4× 2.4k 0.9× 842 0.5× 3.0k 2.0× 608 8.7k
Gregory H. Reaman United States 68 3.1k 0.5× 6.3k 1.6× 3.6k 1.4× 1.3k 0.8× 2.7k 1.8× 306 15.8k
Alison W. Loren United States 32 1.4k 0.2× 2.5k 0.6× 2.9k 1.1× 1.2k 0.8× 566 0.4× 175 7.1k
Ravi Bhatia United States 85 8.9k 1.4× 4.5k 1.2× 5.9k 2.3× 1.7k 1.1× 4.4k 3.0× 463 21.8k
Willem A. Kamps Netherlands 54 1.8k 0.3× 3.0k 0.8× 1.8k 0.7× 587 0.4× 613 0.4× 177 8.4k
Judith D. Goldberg United States 66 1.6k 0.3× 945 0.2× 2.2k 0.8× 939 0.6× 2.0k 1.4× 397 16.0k
John A. Hansen United States 80 11.8k 1.9× 2.4k 0.6× 3.7k 1.5× 13.2k 8.3× 2.3k 1.6× 386 24.6k

Countries citing papers authored by David I. Marks

Since Specialization
Citations

This map shows the geographic impact of David I. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David I. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David I. Marks more than expected).

Fields of papers citing papers by David I. Marks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David I. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David I. Marks. The network helps show where David I. Marks may publish in the future.

Co-authorship network of co-authors of David I. Marks

This figure shows the co-authorship network connecting the top 25 collaborators of David I. Marks. A scholar is included among the top collaborators of David I. Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David I. Marks. David I. Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gökbuget, Nicola, Nicolas Boissel, Sabina Chiaretti, et al.. (2024). Management of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood. 143(19). 1903–1930. 45 indexed citations breakdown →
2.
O’Reilly, Maeve, Michelle Cummins, Emma Nicholson, et al.. (2024). Practice guideline: Preparation for CAR T‐cell therapy in children and young adults with B‐acute lymphoblastic leukaemia. British Journal of Haematology. 204(5). 1687–1696. 1 indexed citations
3.
4.
Wong, Newton A C S & David I. Marks. (2019). How many serial sections are needed to detect apoptosis in endoscopic biopsies with gastrointestinal graft versus host disease?. Journal of Clinical Pathology. 73(6). 358–360. 3 indexed citations
5.
McCune, Jeannine S., Tao Wang, Mahmoud Aljurf, et al.. (2019). Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning. Biology of Blood and Marrow Transplantation. 25(7). 1424–1431. 16 indexed citations
6.
Marks, David I., Qifa Liu, & Monica A. Slavin. (2017). Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation. Expert Review of Anti-infective Therapy. 15(5). 493–502. 13 indexed citations
7.
Marks, David I. & Clare Rowntree. (2017). Management of adults with T-cell lymphoblastic leukemia. Blood. 129(9). 1134–1142. 108 indexed citations
8.
Palmer, Jeanne, Jeannine S. McCune, Miguel‐Angel Perales, et al.. (2016). Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee. Biology of Blood and Marrow Transplantation. 22(11). 1915–1925. 110 indexed citations
9.
Baritussio, Anna, et al.. (2016). Extensive cardiac infiltration in acute T-cell lymphoblastic leukemia: occult extra-medullary relapse and remission after salvage chemotherapy. European Heart Journal. 38(24). ehw393–ehw393. 4 indexed citations
10.
Bow, Eric J., David J. Vanness, Monica A. Slavin, et al.. (2015). Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients. BMC Infectious Diseases. 15(1). 128–128. 44 indexed citations
11.
Rice, Claire M, David I. Marks, Peter Walsh, et al.. (2015). Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II). BMJ Open. 5(9). e009090–e009090. 12 indexed citations
12.
13.
Marks, David I., Antonio Pagliuca, Christopher C. Kibbler, et al.. (2011). Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation. British Journal of Haematology. 155(3). 318–327. 167 indexed citations
14.
McClune, Brian, Daniel J. Weisdorf, Tanya L. Pedersen, et al.. (2010). Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome. Journal of Clinical Oncology. 28(11). 1878–1887. 338 indexed citations
15.
16.
Marks, David I., Elisabeth Paietta, Anthony V. Moorman, et al.. (2009). T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). Blood. 114(25). 5136–5145. 257 indexed citations
17.
Goldstone, Anthony H., Susan Richards, Hillard M. Lazarus, et al.. (2007). In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood. 111(4). 1827–1833. 537 indexed citations breakdown →
18.
Marks, David I.. (2006). Preparations for unrelated donor transplantation. Leukemia & lymphoma. 47(3). 403–408.
19.
Laughlin, Mary J., Mary Eapen, Pablo Rubinstein, et al.. (2005). Outcomes After Transplantation of Cord Blood or Bone Marrow From Unrelated Donors in Adults With Leukemia. Obstetrical & Gynecological Survey. 60(5). 295–296. 131 indexed citations
20.
Marks, David I. & Lucy Yardley. (2004). Research Methods for Clinical and Health Psychology. 659 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henrik Hasle Breakdown of academic impact, for papers by Scott D. Rowley Breakdown of academic impact, for papers by George R. Buchanan Breakdown of academic impact, for papers by Naveen Pemmaraju Breakdown of academic impact, for papers by Gregory H. Reaman Breakdown of academic impact, for papers by Alison W. Loren Breakdown of academic impact, for papers by Ravi Bhatia Breakdown of academic impact, for papers by Willem A. Kamps Breakdown of academic impact, for papers by Judith D. Goldberg Breakdown of academic impact, for papers by John A. Hansen
Rankless by CCL
2026